FinVector Competitors and Similar CompaniesClear all

FinVector's competitors and similar companies include Grindeks and Reneo Pharmaceuticals.

	FinVector FinVector is a company engaged in the research and development of gene and cell therapies.	Grindeks Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.	Reneo Pharmaceuticals Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.
Founding Date	Founding Date 2013	Founding Date 1991	Founding Date 2018
Type	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy
Locations	Locations Kuopio, FI HQ	Locations Rīga, LV HQ Yerevan, AM Bakı, AZ Minsk, BY Tallinn, EE Tbilisi, GE Almaty, KZ see more	Locations San Diego, US HQ Sandwich, GB Irvine, US
Employees	Employees 338	Employees 1,505	Employees 46475% increase
Financial
Net income	Net income N/A	Net income €13.5m (FY, 2019)	Net income ($59.5m) (FY, 2025)

For sources of this data, please see the company profile

Rīga, LV

Employees

1,505

Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.

San Diego, US

Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.

Financial